BPA Call #36C25926N0501

Molecular Thyroid Testing Services Awarded to Cytopath Biopsy Lab

This contract award represents a definitive BPA call under an existing blanket purchase agreement for molecular thyroid testing services. The recipient, Cytopath Biopsy Lab Inc, specializes in laboratory diagnostic services focused on thyroid molecular analysis, supporting healthcare providers with advanced testing. The contract encompasses the initial year of funding for molecular thyroid testing, specifically designed to enhance diagnostic accuracy and patient treatment planning in the medical sector. The work scope includes conducting specialized molecular tests on thyroid tissue samples, delivering detailed analysis reports critical for patient care. This award is significant as it advances the Veterans Affairs' capacity to provide precise diagnostic tools, potentially improving healthcare outcomes for veterans. The contract was awarded as a call against the established Blanket Purchase Agreement 36C25926A0047, ensuring streamlined procurement and service continuity. The contract timeline spans a one-year period commencing in late September 2026, marking the first funded year of the larger multi-year framework. The award supports ongoing efforts in molecular diagnostics within the federal healthcare system, highlighting a crucial partnership with a specialized service provider.

Description

MOLECULAR THYROID TESTING FIRST YEAR FUNDING RMR VA

View original record